Results 1 to 10 of about 52,744 (222)

Assessment of the risks of a myasthenic crisis after thymectomy in patients with myasthenia gravis: a systematic review and meta-analysis of 25 studies

open access: yesJournal of Cardiothoracic Surgery, 2020
Background Despite the burgeoning literature describing preoperative and postoperative risks of a myasthenic crisis after thymectomy (MCAT) in patients with myasthenia gravis, substantial differences exist in the risk factors identified by previous ...
Chaoying Liu   +4 more
doaj   +1 more source

Identification of Potential Serum Protein Biomarkers in Thymoma with Myasthenia Gravis After Docetaxel Treatment

open access: yesNeurology and Therapy, 2023
Introduction Myasthenia gravis (MG) is a devastating acquired autoimmune disease that can seriously affect the patient’s quality of life. It is also a common complication of thymoma.
Hongxia Yang   +5 more
doaj   +1 more source

Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis

open access: yesBMC Medicine, 2021
Background Myasthenia gravis (MG) is an acquired immune-mediated disorder of the neuromuscular junction that causes fluctuating skeletal muscle weakness and fatigue. Pediatric MG and adult MG have many different characteristics, and current MG diagnostic
Peng Liu   +10 more
doaj   +1 more source

Is chest tube drainage necessary after subxiphoid thoracoscopic thymectomy?

open access: yesJournal of Cardiothoracic Surgery, 2020
Background Subxiphoid thoracoscopic thymectomy has been increasingly performed in recent years. This study aimed to assess the differences in outcomes between subxiphoid thoracoscopic thymectomy with and without chest tube drainage.
Jiaduo Li   +3 more
doaj   +1 more source

Anxiety and depression in thymoma patients in China before surgery

open access: yesJournal of Cardiothoracic Surgery, 2022
Background The study's goal was to investigate the percentage of anxiety and depression in Chinese thymoma patients before surgery, and also the factors that influence it.
Jiaduo Li, Guoyan Qi, Yaling Liu
doaj   +1 more source

Clinical characteristics and outcome predictors of a Chinese childhood-onset myasthenia gravis cohort

open access: yesFrontiers in Pediatrics, 2022
Myasthenia gravis is an organ-specific autoimmune disease. Currently there is no universal guidelines for childhood-onset myasthenia gravis, therefore, treatment strategies are usually based on the guidelines from adult myasthenia gravis patients.
Lifen Yang   +6 more
doaj   +1 more source

Meta-analysis of subxiphoid approach versus lateral approach for thoracoscopic Thymectomy

open access: yesJournal of Cardiothoracic Surgery, 2020
Background Compared with traditional open surgery for thymectomy, video-assisted thoracoscopic surgery (VATS) reduces hospital stay, decreases postoperative pain, and recovers faster. VATS has become increasingly popular in the past decade.
Jiaduo Li   +4 more
doaj   +1 more source

Effect of Fufang Huangqi Decoction on the Gut Microbiota in Patients With Class I or II Myasthenia Gravis

open access: yesFrontiers in Neurology, 2022
ObjectiveTo investigate the effect of Fufang Huangqi Decoction on the gut microbiota in patients with class I or II myasthenia gravis (MG) and to explore the correlation between gut microbiota and MG (registration number, ChiCTR2100048367; registration ...
Yanghong Chen   +9 more
doaj   +1 more source

Correlation of Prognostic Nutritional Index with Overall Survival of Postoperative Patients with Thymoma

open access: yesZhongliu Fangzhi Yanjiu, 2021
Objective To evaluate the correlation of prognostic nutritional index(PNI) with overall survival of postoperative patients with thymoma. Methods The clinical and pathological data of 173 postoperative patients with thymoma were analyzed retrospectively ...
WANG Yan   +3 more
doaj   +1 more source

Clinical features and HLA typing of immune checkpoint inhibitor-associated myasthenia gravis, myocarditis and myositis

open access: yesFrontiers in Oncology
BackgroundImmune checkpoint inhibitors (ICI) have significantly improved the therapeutic outcomes for various malignant tumors, but they may also trigger severe immune-related adverse events (irAEs), such as myositis, myocarditis and myasthenia gravis ...
Xiaoting Lin   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy